|

ALN-PNP Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Regeneron Pharmaceuticals2

Indications

  • Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)2
  • Liver Disease2
  • Healthy Volunteers1

Coronado, California1 trial

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Southern California Research Center

Phase 2

Glendale, California1 trial

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

California Clinical Trials Medical Group

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.